Hidden behind thromboinflammation: revealing the roles of von Willebrand factor in sickle cell disease pathophysiology
EF Vital, WA Lam - Current opinion in hematology, 2023 - journals.lww.com
The pathophysiology of SCD is multifaceted, as it involves systemwide vascular activation,
altered blood rheology, and the activation of immune responses and coagulative pathways …
altered blood rheology, and the activation of immune responses and coagulative pathways …
Evaluating thromboprophylaxis in the sickle cell disease population: Navigating the evidence gap
J Davila, SH O'Brien, WB Mitchell… - British Journal of …, 2024 - Wiley Online Library
Sickle cell disease (SCD) arises from beta‐globin gene mutations, with global estimates
indicating around 500 000 affected neonates in 2021. In the United States, it is considered …
indicating around 500 000 affected neonates in 2021. In the United States, it is considered …
Predisposing factors and incidence of venous thromboembolism among hospitalized patients with sickle cell disease
MS Ziyadah, EM Mansory, HM Alahwal… - Journal of Clinical …, 2023 - mdpi.com
Though patients with sickle cell disease (SCD) are at risk of developing venous
thromboembolism (VTE), clear estimates of its incidence and predisposing factors in …
thromboembolism (VTE), clear estimates of its incidence and predisposing factors in …
Venous Thromboembolism in Individuals with Sickle Cell Disease: A Narrative Review
Sickle cell disease (SCD) is an inherited hemoglobinopathy characterized by vaso-
occlusion, hemolysis of red blood cells (RBC), and a predisposition for venous …
occlusion, hemolysis of red blood cells (RBC), and a predisposition for venous …